The Alldus Podcast - AI in Action

Today's guest is Tom Chittenden, Chief Data Science Officer at Genuity Science in Boston. Genuity Science is a contract genomics and data-sourcing, analytics and insights organization who partners with global biopharma companies to offer deep end-to-end discovery services aimed at catalyzing precision health and improving the quality of life for patients around the world. Services include population-scale, disease-specific data sourcing, high-quality sequencing, robust statistical analysis, software tools for analyzing large datasets and AI. With over 25 years of experimental and theoretical research experience, Tom is the Global Head of AI and Statistical Machine Learning R&D at Genuity Science where he provides scientific and technical leadership for Genuity's global Data Science Initiatives.  He is also the Founding Director of their Advanced Artificial Intelligence Research Laboratory where their mission is to better understand human disease initiation and progression, as well as share the knowledge that will aid in the development of new translational applications and enhanced medical care. In the show, Tom will discuss: His journey working within Data Science and AI, Genuity Science’s impact in the Healthcare sector, The benefits of applying AI and Machine Learning within Genomics, How AI and Deep Learning will continue to improve treating illnesses, and What excites him for the future of AI in Healthcare

Today's guest is Carsten Ullrich, Director of AI at Centogene in Berlin. Centogene are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives them unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. They focus exclusively on providing the highest quality, patient-centred service and outstanding short turn-around times for analysis. In the show, Carsten will discuss: His 20 years of experience working in AI, How Centogene are applying AI in rare diseases, Challenges they need to overcome, such as data quality, Improving diagnostics and leveraging this for new discoveries, What makes Centogene a great place to work, Their work with COVID-19 Testing, and The possibility of AI with Superhuman capabilities

Today's guest is Michael Martin, CEO at RapidSOS in New York. RapidSOS has created the world’s first emergency response data platform that securely links life-saving data from over 350 million connected devices directly to 911 and first responders in an emergency. Through the platform, they are providing intelligent data that supports over 4,800 Emergency Communications Centers, protecting 90%+ of people in the US, across 250 million emergencies annually. Partnering with innovative companies certified as RapidSOS Ready, they are striving to reach everyone. Together, RapidSOS are empowering a faster and smarter response by sending first responders critical data like your exact location, real-time health information, and crash data. They are united in their commitment to a safer, stronger future where technology and people work seamlessly together to save lives. In the show, Michael will chat about: The motivation for setting up RapidSOS, Using data & new technology to improve public safety agencies, Understanding the key problems they are looking to solve, Adding real business value with Data Science and Analytics, What the ideal Data Science team looks like, Challenges they have overcome to achieve success, & Why he loves his job

Today's guest is Jason Kim, Associate Director of Biomedical Informatics and Jenny Zhang, Director of Genomic Data Science at Immuneering. Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. Utilizing its proprietary Disease Cancelling Technology, the company engineers medicines that reverse a disease signal across many relevant genes. Immuneering’s technologies have proven exceptionally rapid and capital-efficient in creating its pipeline. Concurrent with its internal programs, they provide unparalleled computational biology services to leading pharmaceutical and biotechnology companies. In the show, Jenny and Jason will chat about: Transitioning from academia into industry, How Immuneering are applying AI to improve drug discovery, What makes them stand out from the competition, Interesting projects they are working on, Why they love working at Immuneering, What they look for in the hiring process, & What’s in store for the future

Today's guest is Martin Akerman, CTO and Co-Founder at Envisagenics in New York. Founded in 2014, it is their mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and Artificial Intelligence. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Their breakthrough technology SpliceCore is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data using AI. This is used to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Their in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost and failure risk of drug development programs. In the show, Martin will chat about: Transitioning from academia into industry, The origins of their inspirational work at Envisagenics, The growth they have enjoyed since setting up the company, How to build a successful Data Science team, What excites him for the future at Envisagenics, Challenges they need to overcome to achieve their goals, & How to transition into a career within Healthcare Data

Today's guest is Suman Giri, Director of Data Science & Consulting at CitiusTech in New York. CitiusTech is a specialist provider of healthcare technology services and solutions to healthcare technology companies, providers, payers and life sciences organizations. CitiusTech enables healthcare organizations to drive clinical value chain excellence, across integration & interoperability, data management, performance management, predictive analytics & data science, and digital engagement. With over 4,000 professionals worldwide, CitiusTech helps customers accelerate innovation in healthcare through specialized solutions, healthcare technology platforms, proficiencies and accelerators. Armed with cutting-edge technology & expertise, world-class service quality and a global resource base, CitiusTech consistently delivers best-in-class solutions along with an unmatched cost advantage to healthcare organizations worldwide. In the show, Suman will chat about: CitiusTech’s work in the HealthTech sector, What his role involves as the Director of Data Science, Recent projects that positively impacted clients, Balancing his workload, What he looks for when hiring Data Scientists, & The potential of NLP and imaging applications in the sector

Today's guest is Lars Schwabe, Director of AI, Data Analytics & Blockchain at Lufthansa Industry Solutions in Hamburg. Lufthansa Industry Solutions is a service provider for IT consulting and system integration. This Lufthansa subsidiary helps its clients with the digital transformation of their companies. Its customer base includes companies both within and outside the Lufthansa Group, as well as more than 200 companies in various lines of business. In the show, Lars will tell you about: The work they do at Lufthansa Industry Solutions, How he got interested in AI and Data Science, Establishing an effective data platform at LIS, Fascinating case studies of the success they have brought to Lufthansa, Challenges to overcome working with AI and Data, His contributions to the AI community in Germany, and The importance of Data Privacy

Today's guest is Chris Fernandez, CEO and co-founder at EnsoData. Founded in 2015, EnsoData provides software-­as-­a-­service (SaaS) that enables the discovery, identification, and actionable reporting of critical to understand patterns and trends in health data. EnsoData’s technology unlocks the vast wealth of clinical expertise lying dormant in archived data. Leveraging their big data and analytics engine, EnsoData enables software to automatically perform complex and time-consuming data interpretation previously left to clinicians. Their first product, EnsoSleep, uses big data and advanced algorithms to aid clinicians in diagnosing sleep apnea by automating the analysis of home and in-clinic sleep studies In the show, Chris will chat about: The motivation for setting up EnsoData, Interesting projects they are doing in the Healthcare industry, Applying AI & Machine Learning to diagnose sleep disorders, How the company has evolved in the past few years, Applying previous research into production at EnsoData, and Setting up an effective team to achieve great success.

Today's guest is Ariel Katz, CEO & Co-Founder at H1 in New York. H1 is the first company to arm healthcare and life science companies with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases. Their mission is to create a healthier future and is doing so by delivering a platform that connects stakeholders across the healthcare ecosystem for greater collaboration and discovery. H1 provides real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, helping companies make smarter scientific decisions. Working with medical affairs and strategy teams who span all phases of the development lifecycle, they provide the complete picture of institutions, experts, scholarly content, markets, competitors and new opportunities through research grounded in actual data and clinical findings. In the show,  Ariel will chat about: His journey to co-founding H1, Challenges they overcame to make H1 what it is today, Use cases of the benefits their platform bring to clients in the Healthcare industry, How they are applying Data Science and Machine Learning, What he enjoys about working within startups, How he went about building a successful team, & Plans for the future at H1

Today's guest is Fred Ronnau, Chief Technology Officer at RubiconMD. Founded in 2013 and headquartered in New York, RubiconMD is a web-based eConsult service that enables primary care providers to quickly and easily discuss their cases with top specialists. This way they can provide better care, while also improving the patient experience and reducing costs. Fred is an experienced Chief Operating Officer with a demonstrated history of growing healthcare organizations through services and technology management. He has extensive experience in healthcare technology integration, data analytics and business development, while also applying agile & lean techniques to drive strategy & innovation and business process improvement. In the show, Fred will discuss: His previous experience working in the Healthcare industry, The work he is doing with RubiconMD, How the team are making the most out of their data, The challenges of working with medical data, Balancing the workload as the CTO, The impact of COVID-19 at RubiconMD, & What excites him for the future of the HealthTech sector